Clinical trial NCT06158191 - References

Diet, Healthy — Long-term Benefits of Abdominal Fat Loss in Abdominally Obese Dyslipidemic Patients (SYNERGIE Study)

Citation(s)

•   Barrett-Connor EL
  Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1010-9. doi: 10.7326/0003-4819-103-6-1010.
•   Bray G, Bouchard C, James W
  Handbook of obesity. United States of America: Marcel Dekker, Inc.; 1998
•   Burnham KP, Anderson DR
  Model Selection and Inference. A Pratical Information-Theoretic Approach. Springer; 1998: Chapters 2.2, 2.4, pp43-48, pp51-54.
•   Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriege P, Despres JP
  Postprandial triglyceride response in visceral obesity in men. Diabetes. 1998 Jun;47(6):953-60. doi: 10.2337/diabetes.47.6.953.
•   Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C
  Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1932-8. doi: 10.1161/01.atv.20.8.1932.
•   Despres JP, Moorjani S, Ferland M, Tremblay A, Lupien PJ, Nadeau A, Pinault S, Theriault G, Bouchard C
  Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat. Arteriosclerosis. 1989 Mar-Apr;9(2):203-10. doi: 10.1161/01.atv.9.2.203.
•   Despres JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien PJ, Theriault G, Pinault S, Bouchard C
  Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes. 1989 Mar;38(3):304-9. doi: 10.2337/diab.38.3.304.
•   Despres JP
  Lipoprotein metabolism in visceral obesity. Int J Obes. 1991 Sep;15 Suppl 2:45-52. No abstract available.
•   Després JP
  Obesity and lipid metabolism: relevance of body fat distribution. Curr Opin Lipidol. 1991;2:5-15.
•   Despres JP
  The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease? CMAJ. 1993 Apr 15;148(8):1339-40. No abstract available.
•   Després JP
  Visceral obesity: A component of the insulin resistance-dyslipidemic syndrome. Can J Cardiol. 1994;10:17B-22B.
•   Doucet E, Imbeault P, Almeras N, Tremblay A
  Physical activity and low-fat diet: is it enough to maintain weight stability in the reduced-obese individual following weight loss by drug therapy and energy restriction? Obes Res. 1999 Jul;7(4):323-33. doi: 10.1002/j.1550-8528.1999.tb00415.x.
•   Doucet E, St-Pierre S, Almeras N, Imbeault P, Mauriege P, Pascot A, Despres JP, Tremblay A
  Reduction of visceral adipose tissue during weight loss. Eur J Clin Nutr. 2002 Apr;56(4):297-304. doi: 10.1038/sj.ejcn.1601334.
•   Hubert HB, Feinleib M, McNamara PM, Castelli WP
  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983 May;67(5):968-77. doi: 10.1161/01.cir.67.5.968.
•   Kissebah AH, Freedman DS, Peiris AN
  Health risks of obesity. Med Clin North Am. 1989 Jan;73(1):111-38. doi: 10.1016/s0025-7125(16)30695-2.
•   Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group
  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393-403. doi: 10.1056/NEJMoa012512.
•   Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW Jr, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL
  AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000 Oct 31;102(18):2284-99. doi: 10.1161/01.cir.102.18.2284. No abstract available.
•   Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, Bergeron J, Despres JP
  Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):961-7. doi: 10.1161/01.atv.21.6.961.
•   Lemieux S, Despres JP, Moorjani S, Nadeau A, Theriault G, Prud'homme D, Tremblay A, Bouchard C, Lupien PJ
  Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia. 1994 Aug;37(8):757-64. doi: 10.1007/BF00404332.
•   Lemieux S, Despres JP
  Metabolic complications of visceral obesity: contribution to the aetiology of type 2 diabetes and implications for prevention and treatment. Diabete Metab. 1994 Jul-Aug;20(4):375-93. No abstract available.
•   Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens CH
  A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990 Mar 29;322(13):882-9. doi: 10.1056/NEJM199003293221303.
•   National Institutes of Health
  The practical guide. Identification, evaluation, and treatment of overweight and obesity in adults. National Heart, Lung, and Blood Institute and North American Association for the Study of Obesity; October 2000:1-77
•   Obesity: preventing and managing the global epidemic
  Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.
•   Pare A, Dumont M, Lemieux I, Brochu M, Almeras N, Lemieux S, Prud'homme D, Despres JP
  Is the relationship between adipose tissue and waist girth altered by weight loss in obese men? Obes Res. 2001 Sep;9(9):526-34. doi: 10.1038/oby.2001.69.
•   Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, Lamarche B, Despres JP
  Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res. 2001 Dec;42(12):2007-14.
•   Pouliot MC, Despres JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, Tremblay A, Bouchard C
  Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes. 1992 Jul;41(7):826-34. doi: 10.2337/diab.41.7.826.
•   Tchernof A, Labrie F, Belanger A, Prud'homme D, Bouchard C, Tremblay A, Nadeau A, Despres JP
  Androstane-3alpha,17beta-diol glucuronide as a steroid correlate of visceral obesity in men. J Clin Endocrinol Metab. 1997 May;82(5):1528-34. doi: 10.1210/jcem.82.5.3924.
•   Tchernof A, Lamarche B, Prud'Homme D, Nadeau A, Moorjani S, Labrie F, Lupien PJ, Despres JP
  The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 1996 Jun;19(6):629-37. doi: 10.2337/diacare.19.6.629.
•   Tremblay A, Despres JP, Maheux J, Pouliot MC, Nadeau A, Moorjani S, Lupien PJ, Bouchard C
  Normalization of the metabolic profile in obese women by exercise and a low fat diet. Med Sci Sports Exerc. 1991 Dec;23(12):1326-31.
•   Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group
  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343-50. doi: 10.1056/NEJM200105033441801.

Abdominal Obesity as a Therapeutic Target: Long-term Benefits of Abdominal Fat Loss and Weight Stabilization in High-risk Abdominally Obese Dyslipidemic Patients With the Features of the Metabolic Syndrome (SYNERGIE Study)

Details for clinical trial NCT06158191